Introduction
============

The birth of molecular biology would have been inconceivable without the aid of bacteriophages. Not only were basic molecular processes, like replication, transcription regulation or recombination first studied in these systems, but they also provided inevitable tools for cloning and sequencing. Transduction, a technique once central to genetic mapping, is still widely used in bacterial genome engineering. Phage typing and phage display are two further important methods in microbiology and in the study of protein--protein interactions respectively.

Phage therapy, the use of hypervirulent (non‐lysogenizing) bacteriophages to eliminate bacterial infections preceded molecular biology by several decades. This technique seems to have found its place in veterinary sciences and the food industry (for review, see [@b2]), as the routine addition of antibiotics to livestock‐feed is becoming banned in an increasing number of countries. Phages used for such purposes are usually sought for in classical selection schemes, but with the exponential expansion of phage genome sequences, their targeted manipulation is also becoming a realistic demand. Altering host specificity, elimination of potential bacterial virulence genes and decreasing antigenicity are examples of tasks that would certainly benefit from a simple and rapid method for phage genome engineering in the lytic state.

A parallel need for engineering phages during their lytic cycle emerged in the course of our research. We have previously reduced the genome of *Escherichia coli* K‐12 strain MG1655 by sequentially deleting 42 genomic segments, a total of 14.3% of the genome ([@b44]). In the course of the project, we removed all mobile elements (ISes, prophages, recombination hot spots) from the genome, thereby significantly reducing the spontaneous mutation rate of the engineered strain, MDS42. The impact of the lack of IS elements on the rate of gene inactivation is especially pronounced under conditions of various stressors ([@b1]; [@b27]; [@b41]; [@b47]; [@b30]; [@b15]; [@b28]; [@b25]; [@b12]) or when focusing on genetic systems that favour insertions over other mutational mechanisms ([@b49]; [@b26]; [@b21]; [@b56]). An example demonstrating both factors was recently described in an experimental system where the reintroduction of a single IS*1* into MDS42 dramatically accelerated the mutational inactivation of a toxic cloned gene ([@b60]). Consequently, to keep genetic stability at its maximum, it is important to avoid the re‐entry of transposable elements in the course of genome engineering carried out in MDS42 and its derivates.

Phage P1 is one of the most widely used tools for general transduction when engineering enterobacterial genomes. Two of its strains have been sequenced to date (phage P1 *mod749*::IS*5 c*1‐100 and prophage P1*mod1902*::IS*5 c*1‐100 *rev‐6 dmt*\_MB, GenBank Accession No. AF234172 and AF234173 respectively) ([@b31]). It was found that both carry single copies of IS*1* and IS*5* in their DNA. This raised the possibility that the use of P1 might result in the inadvertent transfer of IS sequences into the target genome. This would be undesirable and we decided to avoid it by constructing an IS free P1. As starting point, we decided to use P1vir, the hypervirulent, non‐lysogenizing version ([@b33]) to pursue this goal because it also eliminates the possibility of another type of genome contamination, the production of P1 lysogens. This introduced an additional complication, since phage genome engineering is most easily done in the lysogenic form. Bacteriophage recombineering using electroporated DNA (BRED), offered a possible solution by allowing the modification of phages in the lytic state ([@b35]). This method, described recently for mycobacteriophage engineering, employs bacterial overexpression of cloned phage recombinases to assemble phage genomes from purified phage DNA, and synthetic DNA fragments of choice.

In this article we report that P1vir contains a single IS*1*, demonstrate that it is capable of transposition, present the construction of an IS‐free P1vir phage using BRED, and verify its ability to carry out generalized transduction efficiently.

Results
=======

Screening of the P1vir genome for ISes
--------------------------------------

To test which IS elements might be present in the genome of P1vir, test PCRs were applied to the P1vir phage lysate using the primer collection of the White Glove IS Detection Kit, targeting all ISes occurring in *E. coli*. Since phage lysates inevitably carry DNA contamination originating from the host bacteria, the phages to be screened were grown on MDS42+MD64 cells, which provided an IS‐free background. (Deletion MD64 removes a supposedly inactive IS*609* that was identified after construction of IS‐free MDS42.) Besides the control reaction, only the PCR targeting IS*1* yielded a strong band upon gel electrophoresis (Fig. S1A), indicating the presence of this element in P1vir. Although this experiment gave no information on the copy number or the location of IS*1* in P1vir, we hypothesized that at least one copy is the 'resident IS*1*' ([@b22]) lying in the same position and orientation as in the sequenced P1 strains. This was confirmed by a PCR reaction carried out with primers IS1A1 and P1D (Fig. S2), and the specific IS*1* was designated IS*1*~P1vir~ ([Fig. 1](#f1){ref-type="fig"}).

![Map of the IS*1*~P1vir~ region. Small filled arrows depict PCR primers, large open arrows mark genes. Numbers indicate primer coordinates, related to the P1*mod749*::IS*5;c*1‐100 sequence. IRR: right inverted repeat of IS*1*; IRL: left inverted repeat of IS*1*; T: *Rho*‐independent transcription terminator. Drawing is not to scale.](mbt0005-0466-f1){#f1}

Examining the transpositional activity of IS*1*~P1vir~
------------------------------------------------------

Activation of the cryptic *bgl* operon in *E. coli* K‐12, known to occur primarily via IS transposition events, allows growth on salicin‐minimal medium, providing a convenient test system for detecting transpositional activity. To test whether it is capable of transposition, IS*1*~P1vir~, along with its flanking sequences, was cloned into a low‐copy temperature‐sensitive vector (pST76‐AYeaJ), and propagated in *E. coli* MDS42 cells at 30°C. MDS42/pST76‐AYeaJP1IS was plated on salicin‐minimal medium to select for spontaneous mutations activating the cryptic *bgl* operon ([@b20]). At 30°C, when pST76‐AYeaJP1IS plasmid is able to replicate, PCR screening of the *bgl* region of the arising colonies indicated that 100% (48/48) of the tested *bgl*^+^ mutants harboured an insertion in the *bgl*R region. Sequencing one of the relevant PCR fragments yielded a sequence 100% identical to IS*1*~P1vir~, embedded in *bgl*R, indicating that IS*1*~P1vir~ is capable of transposition. The mutation rate calculated from the number of colonies was approximately three times higher than for MDS42Yea : IS*1*, an *E. coli* harbouring a single genomic copy of wild‐type (wt) IS*1* ([Fig. 2](#f2){ref-type="fig"}). At 37°C, when pST76‐AYeaJP1IS is not able to replicate as a plasmid, and antibiotic selection results in its integration into the genome in a single copy, 93% (45/48) of the colonies were insertion mutants, and the mutation rate was similar to that of MDS42Yea : IS*1* at 37°C.

![Mutation rates of *E. coli* strains harbouring a single copy of IS*1* in the genome (MDS42Yea : IS*1*, 37°C), a single copy of IS*1*~P1vir~ in the genome (MDS42 pST76‐AYeaJP1IS, 37°C) and IS*1*~P1vir~ on a low‐copy plasmid (MDS42 pST76‐AYeaJP1IS, 30°C). Error bars indicate 95% confidence intervals.](mbt0005-0466-f2){#f2}

Deletion of IS*1*~P1vir~ from P1vir
-----------------------------------

P1virΔIS was constructed by deleting IS*1*~P1vir~, as described in *Experimental procedures*. Briefly, the genomic segment containing the deletion joint was assembled using overlapping PCR fragments. A mixture of this DNA fragment and the genomic DNA of P1vir was electroporated into a host expressing the λ‐red recombinases, allowing assembly of both wt and IS‐free P1 genomes. Host cells were plated in soft agar, and the emergence of plaques indicated successful assembly of phage genomes, despite the inevitable presence of double‐stranded breaks in the P1 chromosome (no plaques appeared when transforming λ‐red recombinase‐negative cells with P1 DNA). Plaques were picked, and the agarose plugs were digested with agarase to increase the number of released virions. Screening was done using a primer that spans the deletion (P1test), and a primer that anneals to the unaltered part of the phage genome (P1D) ([Fig. 3A](#f3){ref-type="fig"}). The ratio of P1 DNA to the linear DNA fragment, the agarase treatment, as well as the incubation time after electroporation were all varied to optimize the BRED process (Table S1). In an optimal case, four out of 24 plaques tested positive. One mixed plaque, identified this way, was re‐plated on a bacterial lawn to obtain plaques that are either purely wt or purely recombinants. Four out of 15 plaques turned out to harbour recombinant P1virΔIS. Phage lysates generated from such pure recombinant plaques were confirmed to carry the deletion by PCR, using primers P1 BP and P1D ([Fig. 3B](#f3){ref-type="fig"}). P1virΔIS was grown on MDS42+MD64 for another round of IS‐screening, performed using the White Glove IS Detection Kit. The test kit indicated no further copies of IS*1*, or any other transposable element of *E. coli* to be present in the phage genome (Fig. S1B).

![A. PCR screening, using primers P1D and P1test, of plaques obtained upon phage recombineering. Lanes 4 and 11 contain PCR products that indicate the presence of P1virΔIS within the plaques. B. PCR verification of the shortening of the IS‐deleted region in a pure P1virΔIS lysate using primers P1D and P1 BP. M: 1 kb DNA ladder (Fermentas).](mbt0005-0466-f3){#f3}

Characterization of P1vir*Δ*IS
------------------------------

Phage P1virΔIS was grown on *E. coli* MG1655, and was titred as described in *Experimental procedures*. The mean phage titre was 1.16 × 10^10^ plaque forming units (pfu) ml^−1^, which falls in range of that of P1vir lysates, generated by the same protocol. Dependence of phage titre on multiplicity of infection (moi) yielded a similar tendency for both phages (Fig. S3). Moreover, based on plaque morphology, P1virΔIS is indistinguishable from P1vir (Fig. S4). The one‐step growth curves of P1virΔIS and P1vir are compared on [Fig. 4](#f4){ref-type="fig"}. The latency time, rise period, and the burst size of the two phages are also basically identical ([Fig. 4](#f4){ref-type="fig"}).

![One‐step growth curves of P1vir (filled triangles) and P1virΔIS (open diamonds).](mbt0005-0466-f4){#f4}

Next, competition experiments were carried out between P1vir and P1virΔIS to test whether removal of IS*1*~P1vir~ from P1vir has a fitness cost. The mixture was grown on *E. coli* MG1655 for seven transfers, corresponding to 25--30 phage generations. The initial P1vir : P1virΔIS ratio of 11:27 displayed an insignificant change to 10:19 (*P* = 0.63).

To test the ability of P1virΔIS for general transduction, a cyan fluorescent protein gene, linked to a Cm^R^ marker on a 3 kb genomic segment, was transduced to a *lacZ*Δ*M15* acceptor strain, using the protocol described in *Experimental procedures*. The obtained colonies were PCR‐screened for the transferred CFP gene as well as the recipient‐specific *lac* allele on a routine basis. In each transduction experiment, PCR fragments generated with primers ClaGFP/RihE or Zup/Zdn yielded fragments of the expected sizes (1700 bp and 400 bp respectively), verifying the presence of both markers within each tested colony. The efficiency of transduction for P1virΔIS was 3.04 × 10^−6^ transductants/phage (± 2.19 × 10^−6^), which is not significantly different from the value for P1vir (2.16 × 10^−6^ ± 1.51 × 10^−6^, *P* = 0.44).

Discussion
==========

In our pursuit to reduce the chances of IS contamination during P1 transduction, our first question was whether P1vir had, similarly to its relatives, picked up and retained any ISes from the *E. coli* genome. Using a multi‐step PCR analysis, we localized a copy of IS*1* in P1vir present in the same locus as in the sequenced P1 genomes. Sequencing of IS*1*~P1vir~ revealed that, besides the two polymorphisms found in the IS*1* of sequenced P1 strains, IS*1*~P1vir~ harbours seven more point mutations ([Table 1](#t1){ref-type="table"}). Eight of the polymorphisms are present in various combinations in numerous IS*1* elements of *E. coli* and its plasmids, possibly indicating that they do not inhibit transposition. The only mutation specific to IS*1* elements in the three P1 genomes is the G \> T transversion within the IR repeat. Since this latter mutation made annotators question its activity, we set out to test whether IS*1*~P1vir~ is capable of transposition. In wt *E. coli* cells starving on salicin‐minimal medium, salicin breakdown is activated in 97% of the cases by an insertion sequence integrating upstream of the *bgl* operon ([@b20]). This system is such a sensitive indicator of active IS*1* elements that a single copy reintroduced into the genome of MDS42 increases the frequency of *bgl*+ mutants ninefold (T. Fehér, B. Bogos, O. Méhi, G. Fekete, B. Csörgö, K. Kovács, G. Pósfai, B. Papp, L.D. Hurst, C. Pal, submitted). In our experiment, propagating IS*1*~P1vir~ in MDS42 either on a low‐copy plasmid or on the genome, IS*1*~P1vir~ was responsible for the majority of the *bgl*‐activating mutations. Quantitative analysis of its rate of insertion into *bgl*R indicated a transposition rate comparable to that of other IS*1* elements ([Fig. 2](#f2){ref-type="fig"}).

###### 

Single‐nucleotide polymorphisms (SNPs) of IS*1*~P1vir~, as compared with IS*1B* (Accession No. X17345) of *E. coli*

  SNP              Locus (bp)
  ---------------- ------------
  T \> C           128
  C \> A           262
  C \> A           298
  C \> T           301
  T \> C           304
  A \> C           393
  C \> T           396
  *T* \> *G*       *486*
  ***G* \> *T***   ***757***

The SNPs also found in the sequenced P1 genomes are in italics, the one in the IR repeat is in bold.

Insertion sequences have been reported on numerous occasions to dominate the mutations inactivating various genetic constructs propagated in *E. coli* ([@b50]; [@b40]; [@b9]; [@b38]; [@b45]; [@b48]; [@b60]). In most of these cases, the selective advantage of the inactivated construct over the correct one was readily apparent. But can a transducing P1vir phage grown on an IS‐free donor strain serve as a source of ISes? Such an event requires that, upon P1 infection, the phage IS transposes into the host genome, followed by packaging of the IS‐carrying genomic segment into a P1 phage head during lytic growth. Transposition of various insertion sequences into the P1 prophage has been extensively studied by Werner Arber and colleagues ([@b24]). The group has also reported the transposition of IS*1* from the prophage into the pBR325 plasmid ([@b36]; [@b23]), therefore, transposition of IS*1* from the circularized P1 DNA into the host chromosome upon lytic growth is also a realistic scenario. The chance of IS*1* integrating within 110 kb (the maximum distance for co‐transduction) of a given selective marker in the genome is approximately 10^−7^ per cell (see *Supporting information* for details). This means that, upon lysis, only a minute fraction of the selectable transducing virions is expected to carry the IS, suggesting that contamination of the genome in routine marker‐driven genome manipulation processes using P1 transduction ought to be extremely rare. However, if P1 transduction is serially applied in combinatorial genome engineering and batch selection experiments, used for the transfer of multiple unknown alleles, emergence of IS*1*~P1vir~ in the population becomes a realistic event. In such cases, the provided increase in evolutionary potential may facilitate escaping the burden of carrying certain genetic constructs, thereby allowing the rapid expansion of the small IS‐acquiring subpopulation. In light of these considerations, and to stay on the safe side of marker‐driven transduction, the elimination of ISes from P1 seemed worthwhile.

Deletion of IS*1*~P1vir~ from the P1vir genome was accomplished using BRED, resulting in IS‐free P1virΔIS. Table S1 lists the details of our attempts to engineer P1virΔIS, along with the detected frequency of mixed plaques. It is apparent that liberation of the virions from the agarose plugs was necessary to detect the presence of recombinant phages. Melting the plugs was quite effective, but inactivated the phages, therefore we used agarase treatment for this purpose, with a minimal time span of 4 h. Increasing the incubation time to 40 min in‐between electroporation and plating, thereby allowing the amplification of phages, improved the success rate, presumably by increasing the quantity of recombinant phages above the threshold of detection. Electroporation of 100 ng of P1 DNA, along with 200--300 ng of linear DNA fragment, and applying the protocol described below resulted in straightforward and reproducible recombineering the P1vir genome.

To the best of our knowledge, this was the first example of using the λ phage recombinases for engineering a coliphage in the lytic state. λ‐red recombinases have been successfully applied previously for genome engineering in *Salmonella enterica* serovar Typhimurium ([@b55]), *S. enterica* serovar Enteritidis ([@b32])*, Shigella flexneri* ([@b5]; [@b63]), *Shigella sonnei* ([@b59]), *Klebsiella pneumoniae* ([@b62]), enterohaemorrhagic and enteropathogenic *E. coli* ([@b39]), uropathogenic *E. coli* ([@b16]), *Yesinia pestis* ([@b58]), *Yersinia pseudotuberculosis* ([@b14]), *Pseudomonas aeruginosa* ([@b29])*, Serratia marcescens* ([@b51]) and *Vibrio anguillarum* ([@b57]), suggesting that using the same enzymes for recombineering their bacteriophages should be effective. Most of the bacteria listed above generated interest due to their pathogenicity, and are consequently potential targets of phage therapy, as well. BRED could therefore become a valuable tool of 'phage therapists' for targeted engineering of phage genomes. Phage‐mediated biocontrol is already successfully used for the elimination of various *Salmonella typhimurium* ([@b6]; [@b18]) and *E. coli* strains ([@b54]; [@b4]), as well as *Pseudomonas* ([@b19]) and *Vibrio* species ([@b10]) in agriculture and the food industry. Circumventing the need to generate temperate phage strains or to clone their genomes into various vectors could significantly speed up the engineering and development of therapeutic phages, generally classified as hypervirulent. The ongoing reduction in the cost of gene synthesis should enhance the use of BRED to engineer ever‐larger segments of phage genomes using synthetic genes.

A potential by‐product of this work was the accumulation of information regarding the function of the genes flanking IS*1*, and on the role of IS*1* in their transcriptional regulation. Gene *isaA* encodes a 36 kDa protein of unknown function, which is absent from the closely related phage P7. It has no separate promoter, but lies within an operon with the upstream *ssb* gene (encoding a single‐stranded DNA‐binding protein), regulated by a σ70‐dependent promoter and a cI‐binding operator ([@b31]). Transcription of the negative DNA strand, originating from IS*1*~P1vir~ is unlikely to interfere with *isaA* expression due to the presence of a *Rho*‐independent terminator located in‐between the two elements, abolishing transcription from the direction of *insB* ([Fig. 1](#f1){ref-type="fig"}).

*isaB* encodes a 23 kDa protein, the function of which is also unknown. Contrary to *isaA*, *isaB* has its own σ70‐dependent promoter, and is not controlled by the main phage repressors, cI or Lpa. Its extensive richness in AT, as well as the presence of the rare ATA codon and CTAG (the most infrequent tetramer of P1), indicates that it is a recent acquisition of the P1 genome ([@b31]). The TTGGCA within the left inverted repeat (IRL) of IS*1*~P1vir~, together with the genomic AATATGC found 18 bp downstream, may act as '−35' and '−10' regions, respectively, composing an outward pointing promoter ([@b46]). This, as well as the inward pointing promoter activity of the right inverted repeat (IRR) ([@b34]), may increase the expression level of *isaB*. This facilitation of transcription was not investigated in our work, but even if present, it confers the phage no measurable fitness advantage in the lytic cycle, as seen in our competition experiments.

In the course of our rapid characterization, we found no particular changes in phenotype caused by the engineering process, and therefore gained no further information of the roles of *isaA* and *isaB*. We conclude that IS*1*~P1vir~ plays no detectable function in the lytic state of P1vir. One cannot rule out the possibility, however, that the resident IS*1* elements of temperate P1 phages do provide the prophages, or their host bacteria a primary fitness gain \[similarly to the interruption of the restriction‐modification genes of P1 by an IS*5* ([@b31])\], or possibly a second‐order selective advantage by increasing their evolutionary potential ([@b61]). From the practical point of view, P1virΔIS maintains its capacity of general transduction, a property we have taken advantage of in eight further genome engineering steps carried out in *E. coli* to date (data not shown).

In the work described above, we have engineered an IS‐free P1 phage for generalized transduction. We have also shown that the λ‐red recombinase system can be successfully used for recombineering coliphages in their lytic state.

Experimental procedures
=======================

Buffers and media
-----------------

Buffer Φ80+, containing 0.1 M NaCl, 0.01 M Tris (pH 7.9), 0.01 M CaCl~2~ and 0.01 M MgCl~2~, was used for making all phage dilutions ([@b7]). TBE buffer contained 45 mM Tris, 45 mM boric acid and 1 mM EDTA ([@b52]). Bacteria were grown in Luria--Bertani (LB) medium ([@b52]) or in minimal salts (MS) medium ([@b20]). Agar was used in a concentration of 1.5% in plates, and 0.75% in soft agar. In some cases (see below), 0.5% Seakem LE agarose (Lonza, Basel, Switzerland) was used instead of soft agar. Soft agar and soft agarose were always supplemented with 5 mM CaCl~2~ and 5 mM MgSO~4~. Antibiotics (Sigma‐Aldrich, St. Louis, MO, USA) were used in the following end‐concentrations: Chloramphenicol (Cm): 25 µg ml^−1^, Ampicillin (Ap): 50 µg ml^−1^.

Strains and plasmids
--------------------

Phage P1vir was a kind gift of Tamás Gaál. *Escherichia coli* K‐12 MG1655 ([@b8]) and its derivative, MDS42+MD64, were used for phage propagation. Strain MDS42, harbouring a genome reduced by 14.3%, and lacking all active mobile DNA elements, has been described elsewhere ([@b44]). Strain MDS42*lacZ*ΔM15 has the 5′ end of the *lacZ* gene deleted (MG1655 coordinates: 365406 to 365497). In strain MDS42+MD64, the genomic region 1501205--1515026 (MG1655 coordinates) has also been deleted using the suicide plasmid method ([@b43]). This deletion removes IS*609*, an insertion sequence that is inactive due to a premature stop codon in its transposase gene, *yncK*. Strain MDS42*rihB*::(CFP *tetR* Cm^R^) carries a tetracycline‐inducible cyan fluorescent protein gene, along with a repressor and a Cm‐resistance marker within the *rihB* pseudogene ( T. Fehér, B. Bogos, O. Méhi, G. Fekete, B. Csörgö, K. Kovács, G. Pósfai, B. Papp, L.D. Hurst, C. Pal, submitted). Plasmid pKD46 ([@b13]) was a kind gift of Barry Wanner. Plasmid pST76‐A (GenBank Accession No. Y09895.1) has been described previously ([@b42]). Its derivative, pST76‐AyeaJ is a temperature‐sensitive suicide plasmid that was constructed by cloning genomic regions of *E. coli* up‐ and downstream of *yeaJ* ([@b44]). Plasmid pST76‐AyeaJP1IS was constructed by PCR‐amplifying the P1AP30--P1BP30 segment of the P1vir genome ([Fig. 1](#f1){ref-type="fig"}, Table S2), and cloning the phosphorylated fragment into the Klenow‐treated EcoRI site of pST76‐AyeaJ. Strain MDS42Yea : IS*1* harbours a single copy of IS*1* in its genome, integrated into the *yeaJ* gene (T. Fehér, B. Bogos, O. Méhi, G. Fekete, B. Csörgö, K. Kovács, G. Pósfai, B. Papp, L.D. Hurst, C. Pal, submitted).

Phage propagation and titreing
------------------------------

Bacteriophages were grown as described by [@b37]). Host bacteria were grown to 0.5 optical density (OD~540~) in LB medium supplemented with 5 mM CaCl~2~ and 5 mM MgSO~4~. Nine hundred microlitres of the culture was mixed with 100 µl of phage suspension, containing 10^7^--10^8^ pfu ml^−1^. After a 10 min still incubation at 37°C, the mixture was added to 10 ml of fresh LB medium, supplemented with 5 mM CaCl~2~ and 5 mM MgSO~4~, and incubated in a shaker at 37°C. A gradual increase in OD~540~, followed by a sudden drop, usually after 3--4 h, indicated cell lysis. At this point, 50 µl of chloroform was added, and the mixture was vortexed to lyse remaining cells. The lysate was centrifuged at 10 000 *g* for 2 min, and the supernatant was aspirated and stored at 4°C. To measure the titre of the phage lysates, they were serially 10‐fold diluted in Φ80+ buffer, and 100 µl of each dilution was mixed with 100 µl of mid‐log phase (OD~540~ = 0.5) bacteria. After a 10 min still incubation at 37°C, the mixture was added to 3 ml of molten soft agar (kept at 42°C), vortexed and poured onto pre‐warmed LB plates. Plaques appearing on the plates were counted after 16 h of incubation at 37°C, and the titre of the original lysate was calculated in units of pfu ml^−1^.

Screening of the P1vir genome for ISes
--------------------------------------

The White Glove IS Detection Kit (Scarab Genomics, Madison, WI, USA) was used as described in its User Protocol. Briefly, the kit provides primer pairs for PCR detection of IS*1*, IS*2*, IS*3* (IS*Ec17*), IS*4,* IS*5,* IS*10,* IS*30D*, IS*150*, IS*186*, IS*600* (IS*sd1*), IS*609*, IS*911*, IS*Ec1*,*3*,*5*, IS*Ec4, Rhs*A,B,C and *Rhs*D,E. PCR reactions were carried out using *Taq* Polymerase (Fermentas, Vilnius, Lithuania) in 25 µl reaction volumes, each containing 0.5 µl of 100‐fold diluted phage lysate (grown on MDS42+MD64) as a template. Primers P1C1A and P1C1B, amplifying the cI repressor gene, were used for the positive control reaction.

Assaying IS*1* transpositional activity
---------------------------------------

Cells to be assayed (MDS42/pST76‐AyeaJP1IS) were grown to saturation in 20 parallel 1 ml cultures at 30°C, using MS+Ap medium. Cells of each tube were pelleted, and plated onto MS plates supplemented with 0.4% salicin (Alpha Aesar, Ward Hill, MA, USA) and Ap, and incubated at 30°C. To allow for the appearance of slow‐growing pre‐exposure mutants, the appearing colonies were counted and logged daily for 4 days. To calculate the mutation rate, a fluctuation analysis was performed on the colony numbers on day four, using the Ma‐Sandri‐Sarkar maximum likelihood method ([@b53]). Total cell counts were obtained by plating appropriate dilutions onto LB+Ap plates. The ratio of insertion mutants was calculated using colony‐PCR screens amplifying the *bgl*R1--*bgl*R2 region of 48 colonies. Insertion mutants were called when PCR fragments were longer than amplicons obtained from wt cells. One such PCR fragment was sequenced using primers *bgl*R1 and *bgl*R2. The assay measuring IS*1* transpositional activity was repeated at 37°C.

Phage DNA preparation
---------------------

Phage DNA was prepared from phage lysate as described earlier ([@b1001]). Briefly, cell debris was removed from 1 l of phage lysate by centrifugation at 10 000 *g* for 10 min. Phages were precipitated with 5.3% (m/v) PEG6000 overnight at 4°C, followed by pelleting at 3000 *g*. The pellet was resuspended in 30 ml of Suspension Medium (50 mM Tris‐HCl pH 7.5, 0.58% NaCl, 0.1% MgSO~4~ and 0.1% gelatin), and the phage was released from PEG by the slow addition of KCl to a final concentration of 1 M at 4°C. After centrifugation at 10 000 *g* for 10 min, the supernatant (containing the phages) was purified by step gradient centrifugation at 65 000 *g* for 2 h using CsCl solutions of 1.7, 1.5 and 1.3 g ml^−1^. The lowest blue band was recovered from the 1.5 g ml^−1 ^layer, and resuspended in 1.5 g ml^−1^ CsCl for equilibrium gradient centrifugation at 100 000 *g* for 24 h. The blue band was removed, and dialysed twice for 4 h against 500 ml of Low Salt Buffer (50 mM Tris‐HCl pH 7.5, 50 mM NaCl, 10 mM MgSO~4~). Phage capsids were removed by three phenol extractions and two chloroform extractions (20 min each), using the gentle agitation of a shaker to minimize the mechanical damage of the DNA. Finally, we dialysed the DNA against 500 ml of Tris‐EDTA buffer (10 mM Tris‐HCl pH 7.5, 1 mM EDTA) at 4°C for 8 h.

Construction of a linear DNA fragment targeting the phage genome
----------------------------------------------------------------

The P1AP--P1 BP PCR fragment targeting the phage genome was constructed in two steps. First, the P1AP--P1_2R and the P1 BP--P1_2F segments of the P1vir genome were PCR‐amplified using the respective primers. PCR reactions were carried out in volumes of 100 µl using Phusion High Fidelity DNA Polymerase (New England Biolabs, Ipswich, MA, USA) at an annealing temperature of 57°C. The PCR products were purified using the PCR Advanced™ PCR Cleanup System (Viogene, Taiwan, China), and were resuspended in 50 µl of the kit\'s elution buffer. In the second step, 2 µl of both purified PCR fragments were mixed and used as templates in a PCR carried out with primers P1AP and P1 BP using HotMaster DNA Polymerase (Eppendorf AG, Hamburg, Germany). The product of the correct size (1200 bp) was isolated from a 1% agarose gel using the Wizard SV Gel and PCR Clean‐up System (Promega, Madison, WI, USA), and was concentrated with SureClean Plus DNA Purification Kit (BioLine, London, UK) to approximately 150 ng µl^−1^.

Bacteriophage recombineering
----------------------------

Engineering the genome of P1vir was based on the method described by [@b35]). MG1655/pKD46 cells were grown to mid‐log phase at 30°C in the presence of 0.1% arabinose in 100 ml of LB+Ap, and were harvested by centrifugation at OD~540~ = 0.5. In repeated suspension--centrifugation cycles, cells were washed twice in ice‐cold water, and once in ice‐cold 10% glycerol, then suspended in 0.2 ml of ice‐cold 10% glycerol, and divided into 40 µl aliquots ([@b52]). A mixture containing 100 ng of phage DNA and 300 ng of the P1AP--P1 BP PCR fragment was electroporated into an aliquot of MG1655/pKD46 cells at a voltage of 1800 V in a 0.1 cm electroporation cuvette using a Bio‐Rad MicroPulser Electroporator. Next, cells were added to 1 ml of LB medium, and were shaken for 40 min at 37°C. After mixing the suspension with 3 ml of soft agarose, it was poured onto LB plates, and incubated overnight at 37°C. The following day, plaques were picked with a micropipette using cut‐off 200 µl tips. Each aspirated agarose plug was suspended in 20 µl of TBE buffer, supplemented with 0.25 units of agarase (Fermentas, Vilnius, Lithuania). After 4 h of incubation at 42°C, 1 µl of each sample was used directly as a template in 25 µl of PCR reactions screening for recombinants with primers P1test‐P1D, at an annealing temperature of 58°C. Five microlitres of plaque‐suspensions yielding a PCR fragment were mixed with 100 µl of mid‐log‐phase MG1655 cells, and plated in soft agarose. Plaques arising were suspended and PCR screened again, and 5 µl of PCR‐positive plaque suspensions were used to grow pure phage lysates, as described above.

One‐step phage growth experiments
---------------------------------

Growth characteristics of wt and engineered phages were measured by the modified protocol of [@b11]). Briefly, *E. coli* MDS42 was grown to an OD~540~ of 0.6 in LB medium supplemented with 5 mM CaCl~2~ and 5 mM MgSO~4~. One hundred microlitres of bacteria were mixed with 100 µl of phage lysate (10^8^ pfu ml^−1^) to adjust the moi to approximately 0.2. After 1 min incubation at 37°C, the mixture was centrifuged for 40 s at 10 000 *g*. The supernatant, containing unadsorbed bacteriophages, was discarded, and the pellet was resuspended in 30 ml of LB medium supplemented with 5 mM CaCl~2~ and 5 mM MgSO~4~, and was shaken at 37°C at 220 r.p.m. Aliquots of the culture were taken at regular intervals and were diluted 10^3^ and 10^5^‐fold respectively. Each dilution was mixed with 100 µl of mid‐log‐phase MDS42 cells, and was plated in soft agar, as described above. The plaque counts obtained the next day were multiplied by the dilution factor and plotted against the elapsed time to obtain the one‐step growth curves.

P1 transduction
---------------

Transducing phage was grown on the donor cell MDS42*rihB*::(CFP *tetR* Cm^r^) as described above. For transduction, 0.1 ml of fresh overnight culture of the acceptor strain MDS42*lacZ*ΔM15, grown in the presence of 5 mM CaCl~2~ and 5 mM MgSO~4~, was mixed with 0.1 ml of the transducing phage. After incubating the mixture at 37°C for 15 min, 0.5 ml of LB and 35 µl of 1 M Na~3~ citrate were added, and incubation continued for 1 h. Finally, cells were pelleted at 10 000 *g*, plated on LB+Cm plates, and incubated for 36 h at 37°C. Ten colonies from each transduction were checked by colony‐PCR for genetic markers of both the donor and the acceptor cell, using primer pairs ClaGFP5+RihE and Zup+Zdn respectively (Table S2).

To calculate the efficiency of transduction, the number of obtained colonies was divided by the titre of the phage lysate used. A total of six transductions were carried out using three distinct lysates for both P1vir and P1virΔIS, and replicating each experiment.

Phage competition experiments
-----------------------------

Mixtures containing virions of P1vir and P1virΔIS in 1:1 ratios were prepared. The phage mixtures were grown on MG1655 cells for a total of seven rounds of lysis and re‐infection. The exact ratios of the phages in the initial and the final lysate were measured by plating appropriate dilutions onto MG1655 lawns (as described under *Phage propagation and titreing*), and PCR‐screening the obtained plaques using primers P1‐3 and P1D. The significance of the difference in the initial and final ratios was checked with a χ^2^‐test.
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Additional Supporting Information may be found in the online version of this article:

###### 

Results of PCR reactions screening for ISes within the P1vir (A) and P1virΔIS (B) genomes, using the White Glove IS Detection Kit. In both panels, lanes contain primers specific for the following elements: lane 1: IS*1*, lane 2: IS*2*, lane 3: IS*3* (IS*Ec17*), lane 4: IS*4,* lane 5: IS*5,* lane 6: IS*10*, lane 7: IS*30D*, lane 8: IS*150*, lane 9: IS*186*, lane 10: IS*600* (IS*sd1*), lane 11: IS*609*, lane 12: IS*911*, lane 13: IS*Ec1*,*3*,*5*, lane 14: IS*Ec4,* lane 15: *Rhs*A,B,C, lane 16: *Rhs*D,E. Lane 17 contained primers specific for P1 C1 gene. M: 1 kb DNA ladder (Fermentas).

###### 

PCR verification of the position and orientation of IS1P1vir using primers IS1A1 and P1D.

###### 

Dependence of phage titre on multiplicity of infection (moi).

###### 

Comparison of plaque morphology. Left: P1vir. Right: P1virΔIS.

###### 

**Table S1.** Details of attempts to engineer P1virΔIS using BRED. Note that multiple batches of arabinose‐induced electrocompetent MG1655/pKD46 cells were used during the optimization, which could cause inconsistencies.

**Table S2.** Primers used in this study.
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